Exact Sciences (NAS: EXAS)

Exact Sciences is a corporation based in Madison, Wisconsin. Established in 1995, the company specializes in cancer screening and diagnostic tests, aiming to detect cancer early and guide personalized treatment. Its flagship product is Cologuard, the first FDA-approved, noninvasive stool DNA test for colorectal cancer screening. The company also offers Oncotype DX tests for breast and colon cancer recurrence risk, OncoExTra for tumor profiling, and Riskguard for hereditary cancer risk assessment. The assets are managed by the executive team.